NOVARTIS CAP CORP 2.2 percent 14Aug2030 is a Senior Unsecured Note issued by the corporate entity on the 11th of February 2020. NOVARTIS is trading at 87.75 as of the 30th of January 2025, a 0.14% increase since the beginning of the trading day. The bond's open price was 87.63. NOVARTIS has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for NOVARTIS CAPITAL P are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
Our tools can tell you how much better you can do entering a position in NOVARTIS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Performance Analysis Now
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
NOVARTIS financial ratios help investors to determine whether NOVARTIS Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVARTIS with respect to the benefits of owning NOVARTIS security.